Chapter
The Placebo Effect in Antidepressant Medications
03:53 - 14:25 (10:31)
The use of active placebos in antidepressant medication research helps to show the effectiveness of the placebo effect in treating depression. While conventional SSRIs can take six to eight weeks to show effects, ketamine has a rapid onset in certain individuals.
Clips
The use of an active placebo, glycopyronium, was able to produce antidepressant-like effects that were not distinguishable from those produced by an actual antidepressant, suggesting that the placebo effect may be responsible for a significant portion of the antidepressant response.
03:53 - 09:37 (05:44)
Summary
The use of an active placebo, glycopyronium, was able to produce antidepressant-like effects that were not distinguishable from those produced by an actual antidepressant, suggesting that the placebo effect may be responsible for a significant portion of the antidepressant response. This finding could have important implications for reducing healthcare costs associated with mental health issues such as depression and chronic anxiety.
ChapterThe Placebo Effect in Antidepressant Medications
Episode#619: Dr. Suresh Muthukumaraswamy — LSD Microdosing, Classical Psychedelics vs. Ketamine, Science and Speed in New Zealand, Placebo Options, and The Infinite Possibilities of Studying Mind-Altering Compounds
PodcastThe Tim Ferriss Show
Ketamine has different receptor binding profiles and rapid onset effects in certain subjects, making it a promising alternative to traditional SSRIs for treating depression.
09:38 - 14:25 (04:46)
Summary
Ketamine has different receptor binding profiles and rapid onset effects in certain subjects, making it a promising alternative to traditional SSRIs for treating depression. Its diverse receptor binding sites make it a complicated substance to study.